Hirsutism differential diagnosis: Difference between revisions

	Hirsutism Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hirsutism from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Echocardiography or Ultrasonography
Treatment
Medical Therapy; Pharmacological therapy; Non-pharmacological therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hirsutism differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hirsutism differential diagnosis
CDC on Hirsutism differential diagnosis
Hirsutism differential diagnosis in the news
Blogs on Hirsutism differential diagnosis
Directions to Hospitals Treating Hirsutism differential diagnosis
Risk calculators and risk factors for Hirsutism differential diagnosis

Revision as of 01:05, 20 August 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Idiopathic:
- familial,
- possibly increased sensitivity to androgens.
variant of normal menopause.
Polycystic ovarian syndrome.
obesity
Drugs:
- androgens,
- anabolic steroids,
- methyltestosterone,
- minoxidil,
- diazoxide,
- phenytoin,
- glucocorticoids,
- cyclosporine.
- phenytoin,
Congenital adrenal hyperplasia.
Adrenal virilizing tumor.
Ovarian virilizing tumor:
- arrhenoblastoma,
- hilus cell tumor.
Pituitary adenoma.
pregnancy
Insulin resistance
Cushing's syndrome.
Hypothyroidism (congenital and juvenile).
Acromegaly.
Androgen-secreting tumors of the ovaries
- Sertoli-Leydig cell tumors,
- granulosa-theca cell tumors,
- hilus-cell tumors
hyperprolactinemia
Testicular feminization.

@@ Line 8: / Line 8: @@
 ==Differential Diagnosis==
+#Idiopathic:
+#*familial,
+#*possibly increased sensitivity to androgens.
+#variant of normal menopause.
+#Polycystic ovarian syndrome.
+#obesity
+#Drugs:
+#*androgens,
+#*anabolic steroids,
+#*methyltestosterone,
+#*minoxidil,
+#*diazoxide,
+#*phenytoin,
+#*glucocorticoids,
+#*cyclosporine.
+#*phenytoin,
+#Congenital adrenal hyperplasia.
+#Adrenal virilizing tumor.
+#Ovarian virilizing tumor:
+#*arrhenoblastoma,
+#*hilus cell tumor.
+#Pituitary adenoma.
+#pregnancy
+#Insulin resistance
+#Cushing's syndrome.
+#Hypothyroidism (congenital and juvenile).
+#Acromegaly.
+#Androgen-secreting tumors of the ovaries
+#*Sertoli-Leydig cell tumors,
+#*granulosa-theca cell tumors,
+#*hilus-cell tumors
+#hyperprolactinemia
+#Testicular feminization.
 ==References==